Microbot Medical provides update on GLP pre-clinical trial for LIBERTY Robotic System

Comments · 45 Views

Microbot Medical provides update on GLP pre-clinical trial for LIBERTY Robotic System

Microbot Medical provides update on GLP pre-clinical trial for LIBERTY Robotic System

Microbot Medical has announced, as part of the preparation for its anticipated U.S. Food and Drug Administration (FDA) and CE Mark submissions, that it recently shipped multiple LIBERTY Robotic System devices to a market-leading research laboratory to conduct the Company’s GLP pre-clinical trial. The comprehensive trial, which is anticipated to commence later this month, will be performed by a team of global leaders in the endovascular space at a state-of-the-art lab with FDA approved levels of planning, controlling, monitoring and reporting (GLP standards).To get more news about GLP Robotics, you can visit glprobotics.com official website.

“We are very excited to commence the first step of our regulatory process leading to the anticipated clearances for our LIBERTY® Robotic system,” commented Harel Gadot, Chairman, CEO and President. “We are confident the collaboration with a world-leading research institute, coupled with the Key Opinion Leaders performing the study, will allow us to progress as planned.”

GLP, the leading global provider of modern logistics facilities and technology-led solutions, announced today that five additional development projects totaling 518,000 sqm (5.6 million sq ft) in China and Japan have obtained Leadership in Energy and Environmental Design ("LEED") Gold certifications from the US Green Building Council. LEED is the world's most widely recognized and used standard for measuring the performance of green buildings.Ming Mei, Co-Founder and CEO of GLP, said: "GLP continues to lead the development and management of sustainable modern logistics facilities, while accommodating customers' needs to introduce technology such as automation and robotics equipment that enhance operational efficiency."

In China, GLP China has achieved LEED Gold for GLP Park Suzhou in Eastern China. The 83,000 sqm (893,000 sq ft) property is leased by a leading global sports company. This is GLP China's second LEED Gold certification, following the BMW China RD Center in Beijing, Northern China which was completed earlier this year. Both of these properties were build-to-suit developments.

In Japan, GLP has achieved further LEED Gold certifications for four developments in Greater Tokyo and Osaka:GLP Nagareyama is a first-of-its kind fully integrated supply chain facility in Japan where customers can conduct production-related activities at the same location as storage and distribution. Customer demand for this signature development is very strong: GLP Nagareyama is almost fully leased, with Japanese e-commerce leader Rakuten leasing 100% of GLP Nagareyama II.
GLP is a leader in building environmentally-friendly logistics facilities globally, with more than 100 buildings across Brazil, China, Europe, Japan, and the US achieving green building certifications including LEED, BREEAM, and CASBEE. GLP facilities typically feature solar panels, LED lighting, and thermal insulation materials that optimize efficiency for customers.

GLP is one of the largest rooftop solar power providers in Japan and has partnered with Brookfield in China to develop the country's largest rooftop solar platform.